Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi-Aventis Canada Inc.
02 1Blank
01 11194875
02 21336777
03 22334870
01 4Clopidogrel Bisulfate
02 1Blank
01 4Tablet
02 1Blank
01 12003-07-08
02 22012-08-22
03 22019-06-10
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Brand Name : PLAVIX
Patent Number : 2334870
Filing Date : 1999-06-10
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Brand Name : PLAVIX
Patent Number : 1336777
Filing Date : 1988-02-08
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Brand Name : PLAVIX
Patent Number : 1336777
Filing Date : 1988-02-08
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Brand Name : PLAVIX
Patent Number : 2334870
Filing Date : 1999-06-10
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Patent Expiration Date : 2003-07-08
Date Granted :
Brand Name :
Patent Number : 1194875
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2003-07-08
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?